The FDA and CDC found that the company conducts microbiological testing before distributing its infant formula products to consumers. None of its products tested positive for Cronobacter sakazakii or Salmonella.
During the FDA inspection at the Sturgis facility, the agency and the company tested all retained products. The test results came back negative for Cronobacter sakazakii or Salmonella.
The environmental testing showed that Cronobacter sakazakii were present in non-product contact areas of the facility and has not been linked to any infant illnesses.
The genetic sequencing on the two available samples from sick infants did not match the strains of Cronobacter sakazakii found at the Sturgis plant. Samples from the sick infants did not match each other, which means the two cases have no connection.
“Our safety and quality processes meet even the toughest scrutiny and we’re committed to continuously improving our processes and protocols,” said Mr. Ford.
Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.
